RECRUITING

Effectiveness of Dry Needling in Linear Scar Tissue

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Scar tissue can cause serious complications that significantly impact a patient's quality of life. Common complications include stiffness and contractions, which can restrict joint mobility and make daily activities challenging. In severe cases, these limitations can even prevent patients from fulfilling their work responsibilities or engaging in activities they enjoy. The deleterious effect of scar tissue on a patient's well-being is of utmost significance. However, several therapeutic approaches have been proposed to manage scar tissue complications. Enhancing scar tissue compliance can help patients regain their functional abilities and reduce limitations. One such approach is dry needling, a technique used to improve the flexibility of myofascial tightness. Nevertheless, the effectiveness of dry needling in improving scar tissue compliance remains debatable. Therefore, this study aims to investigate the therapeutic effects of dry needling on complications resulting from linear hypertrophic scars caused by surgery or trauma.

Official Title

The Effectiveness of Dry Needling in Treating Linear Hypertrophic Scar Tissue: a Randomized Sham-controlled Trial

Quick Facts

Study Start:2023-10-10
Study Completion:2025-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06033430

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:20 Years to 60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Linear hypertrophic scar tissue with an age of more than six weeks
  2. * No restrictions on active and passive joint range of motion near the scar tissue
  3. * Age between 20 and 60 years
  1. * Needle phobia
  2. * Immature scar or keloid scar
  3. * Skin diseases or infections near the scar tissue
  4. * Diabetes
  5. * Fractures that have altered joint mobility
  6. * Anticoagulant medication use

Contacts and Locations

Study Contact

Mohammadreza Pourahmadi, Ph.D. Postdoc research fellow
CONTACT
+989122245593
pourahmadipt@gmail.com
Maryam Ahmadi, Ms.c.
CONTACT
+989106665134
maryamahmadima226@gmail.com

Study Locations (Sites)

Myopain Seminars
Bethesda, Maryland, 20814-4522
United States

Collaborators and Investigators

Sponsor: Iran University of Medical Sciences

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-10
Study Completion Date2025-06-01

Study Record Updates

Study Start Date2023-10-10
Study Completion Date2025-06-01

Terms related to this study

Keywords Provided by Researchers

  • Hypertrophic scar
  • Dry needling
  • Randomized sham-controlled trial

Additional Relevant MeSH Terms

  • Scar Tissue
  • Hypertrophic Scar
  • Hypertrophic Scar of Upper Arm (Disorder)
  • Hypertrophic Surgical Scar
  • Dry Needling